 Partial reversibility cisplatin nephrotoxicity children long-term renal toxicity cisplatin children treatment months months years children glomerular filtration rate GFR plasma clearance chromium ethylenediaminetetraacetic acid end treatment median follow-up years months treatment months years children serum magnesium level follow-up Median age diagnosis months days years months median cumulative doses cisplatin children end-of-treatment GFR ml/min median improvement GFR follow-up ml/min ml/min Hypomagnesemia children independent GFR No significant correlation improvement renal function total cisplatin dose age gender tumor type nephrotoxic medication children recovery cisplatin glomerular toxicity damage severe hypomagnesemia